08:44 AM EST, 11/04/2025 (MT Newswires) -- Taysha Gene Therapies ( TSHA ) reported a Q3 net loss Tuesday of $0.09 per share, narrowing from a loss of $0.10 a year earlier.

The company didn't report revenue for the quarter ended Sept. 30, compared with $1.8 million a year earlier.

Comparable FactSet estimates were not available.

As of Sept. 30, the company had $297.3 million in cash and cash equivalents.

Shares of the company were down more than 2% in recent Tuesday premarket activity.